Annual Current Liabilities
$5.48 M
-$2.07 M-27.36%
December 31, 2023
Summary
- As of February 7, 2025, CTNM annual total current liabilities is $5.48 million, with the most recent change of -$2.07 million (-27.36%) on December 31, 2023.
- During the last 3 years, CTNM annual current liabilities has risen by +$1.81 million (+49.27%).
- CTNM annual current liabilities is now -27.36% below its all-time high of $7.55 million, reached on December 31, 2022.
Performance
CTNM Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$5.81 M
+$2.07 M+55.28%
September 30, 2024
Summary
- As of February 7, 2025, CTNM quarterly total current liabilities is $5.81 million, with the most recent change of +$2.07 million (+55.28%) on September 30, 2024.
- Over the past year, CTNM quarterly current liabilities has increased by +$322.00 thousand (+5.87%).
- CTNM quarterly current liabilities is now -23.10% below its all-time high of $7.55 million, reached on December 1, 2022.
Performance
CTNM Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
CTNM Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -27.4% | +5.9% |
| 3 y3 years | +49.3% | -23.1% |
| 5 y5 years | +49.3% | -23.1% |
CTNM Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -27.4% | +49.3% | -23.1% | +55.3% |
| 5 y | 5-year | -27.4% | +49.3% | -23.1% | +55.3% |
| alltime | all time | -27.4% | +49.3% | -23.1% | +55.3% |
Contineum Therapeutics Class A Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.81 M(+55.3%) |
| Jun 2024 | - | $3.74 M(-40.0%) |
| Mar 2024 | - | $6.23 M(+13.7%) |
| Dec 2023 | $5.48 M | $5.48 M(-26.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $7.44 M(-1.5%) |
| Dec 2022 | $7.55 M(+105.5%) | - |
| Dec 2022 | - | $7.55 M |
| Dec 2021 | $3.67 M | - |
FAQ
- What is Contineum Therapeutics Class A annual total current liabilities?
- What is the all time high annual current liabilities for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A annual current liabilities year-on-year change?
- What is Contineum Therapeutics Class A quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A quarterly current liabilities year-on-year change?
What is Contineum Therapeutics Class A annual total current liabilities?
The current annual current liabilities of CTNM is $5.48 M
What is the all time high annual current liabilities for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high annual total current liabilities is $7.55 M
What is Contineum Therapeutics Class A annual current liabilities year-on-year change?
Over the past year, CTNM annual total current liabilities has changed by -$2.07 M (-27.36%)
What is Contineum Therapeutics Class A quarterly total current liabilities?
The current quarterly current liabilities of CTNM is $5.81 M
What is the all time high quarterly current liabilities for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high quarterly total current liabilities is $7.55 M
What is Contineum Therapeutics Class A quarterly current liabilities year-on-year change?
Over the past year, CTNM quarterly total current liabilities has changed by +$322.00 K (+5.87%)